The burden of antimicrobial resistance among urinary tract isolates of Escherichia coli in the United States in 2017

por Critchley, Ian A., Cotroneo, Nicole, Pucci, Michael J., Mendes, Rodrigo
Publicado 2019

1637. SPR720, A Novel Benzamidazole Gyrase Inhibitor, Demonstrates Potent Efficacy Against Mycobacterium avium ATCC 700898 in a Chronic C3HeBFeJ Mouse Infection Model

por Verma, Deepshikha, Peterson, Chelsea, Cotroneo, Nicole S, Stokes, Suzanne, Ordway, Diane J
Publicado 2020

1465. Resistance to Oral Antibiotics Among Urinary Tract Infection Isolates of Escherichia coli from the United States and Europe in 2017

por Critchley, Ian A, Cotroneo, Nicole, Sulham, Kate, Melnick, David, Mendes, Rodrigo E
Publicado 2019

1695. Tebipenem: An Oral Carbapenem with activity against Multi-drug Resistant Urinary Tract Infection isolates of Escherichia coli collected from US Medical Centers during 2019

por Critchley, Ian A, Cotroneo, Nicole S, Pucci, Michael J, Jain, Akash, Mendes, Rodrigo E
Publicado 2020

1274. Evaluating the Activity of SPR719, a Novel Aminobenzimidazole, against Nontuberculous Mycobacteria

por Murray, Beverly, Hall, Danielle, Cotroneo, Nicole S, Critchley, Ian, Pucci, Michael, Stokes, Suzanne, Pillar, Chris
Publicado 2020

1044. In vitro Activity of Tebipenem Against Relevant Clinical Isolates in the Presence of Pulmonary Surfactant

por Arends, S J Ryan, Klauer, Abby L, Cotroneo, Nicole, Critchley, Ian A, Mendes, Rodrigo E
Publicado 2021

1041. In vitro activity of tebipenem against a recent collection of fastidious organisms recovered from respiratory tract infections

por Arends, S J Ryan, Klauer, Abby L, Cotroneo, Nicole, Critchley, Ian A, Mendes, Rodrigo E
Publicado 2021

1038. In Vitro Activity of Tebipenem, an Orally Available Carbapenem Agent, Against a Collection of Surveillance Gram-Positive Clinical Isolates

por Arends, S J Ryan, Klauer, Abby L, Cotroneo, Nicole, Critchley, Ian A, Mendes, Rodrigo E
Publicado 2021

1113. Oral Tebipenem as Step-Down Therapy Following Intravenous Ertapenem in a 7-day Hollow-Fiber In Vitro Infection Model

por VanScoy, Brian D, Jones, Sean, Conde, Haley, Friedrich, Lawrence, Cotroneo, Nicole, Ambrose, Paul G
Publicado 2021

In Vitro Resistance against DNA Gyrase Inhibitor SPR719 in Mycobacterium avium and Mycobacterium abscessus

por Aragaw, Wassihun Wedajo, Cotroneo, Nicole, Stokes, Suzanne, Pucci, Michael, Critchley, Ian, Gengenbacher, Martin, Dick, Thomas
Publicado 2022

Contemporary Evaluation of Tebipenem In Vitro Activity against Enterobacterales Clinical Isolates Causing Urinary Tract Infections in US Medical Centers (2019–2020)

por Mendes, Rodrigo E., Arends, S. J. Ryan, Streit, Jennifer M., Critchley, Ian, Cotroneo, Nicole, Castanheira, Mariana
Publicado 2023

1659. Pharmacokinetics/pharmacodynamics of the Novel Gyrase Inhibitor SPR719/SPR720 and Clinical Dose Selection to Treat Pulmonary Mycobacterium avium-complex Disease

por Deshpande, Devyani, Kuret, Daniel, Cirrincione, Kayle, Cotroneo, Nicole, Melnick, David, Lister, Troy, Stokes, Suzanne, Gumbo, Tawanda
Publicado 2020

1057. Tebipenem In vitro Activity Against a Collection of Pathogens Responsible for Urinary Tract Infections in the US

por Mendes, Rodrigo E, Critchley, Ian A, Cotroneo, Nicole, Streit, Jennifer M, Sader, Helio S, Castanheira, Mariana, Castanheira, Mariana
Publicado 2021

1281. An Evaluation of Tebipenem In Vitro Activity Against a Panel of Pseudomonas aeruginosa Isolates with Efflux, AmpC, and OprD Mutations

por VanScoy, Brian D, Conde, Haley, Cotroneo, Nicole, Critchley, Ian A, Parr, Thomas R, Ambrose, Paul G
Publicado 2021

150. Low Propensity for Development of Spontaneous In Vitro Resistance to Tebipenem, Ertapenem and Meropenem Among Enterobacterales Uropathogens

por VanScoy, Brian D, Conde, Haley, Mendes, Rodrigo E, Cotroneo, Nicole, Critchley, Ian A, Critchley, Ian A
Publicado 2022

1254. Molecular Epidemiology of Escherichia coli Causing Urinary Tract Infections in United States and in vitro Activity of Tebipenem, Including Against Strain Lineage and Resistan...

por Mendes, Rodrigo E, Doyle, Timothy B, Critchley, Ian A, Cotroneo, Nicole, Streit, Jennifer M, Castanheira, Mariana, Castanheira, Mariana
Publicado 2021

1095. Pharmacokinetics-Pharmacodynamics Evaluation of Tebipenem Pivoxil Hydrobromide Using the 10-Day Hollow-Fiber In Vitro Infection Model

por VanScoy, Brian D, Conde, Haley, Jones, Sean, Critchley, Ian A, Parr, Thomas R, Cotroneo, Nicole, Ambrose, Paul G
Publicado 2021

1304. Characterization of Tebipenem Pivoxil Hydrobromide Pharmacokinetics-Pharmacodynamics (PK-PD) in a Neutropenic Murine Acute Pyelonephritis (AP) Model

por VanScoy, Brian D, Fikes, Steven, Rubino, Christopher M, Bhavnani, Sujata M, Cotroneo, Nicole S, Critchley, Ian A, Parr, Thomas R, Ambrose, Paul G
Publicado 2020

1565. Characterization of Tebipenem (SPR859) Pharmacokinetics–Pharmacodynamics (PK-PD) for Efficacy Against Enterobacteriaceae in a One-Compartment In Vitro Infection Model

por VanScoy, Brian D, Onufrak, Nikolas J, Conde, Haley, Caranco, Ana I, Bhavnani, Sujata M, Cotroneo, Nicole, Critchley, Ian A, Parr, Thomas R, Ambrose, Paul G
Publicado 2019